Search

everythinglearnresearchcommunity

for

Search:↓

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

PCOS is caused by both genetics and environmental factors like diet and obesity.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Hirsutism is when women have too much hair growth, often due to a bit more androgen hormones and sensitive skin.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Spironolactone plus finasteride reduces hirsutism more effectively.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Certain hormone treatments can improve acne and related conditions in women.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.